Postvaccination COVID-19 infection is associated with reduced mortality in patients with cirrhosis.

Binu V JohnYangyang DengKaley B SchwartzTamar H TaddeiDavid E KaplanPaul MartinHann-Hsiang ChaoBassam Dahman

Published in: Hepatology (Baltimore, Md.) (2022)

Though patients with cirrhosis can develop breakthrough COVID-19 after full or partial vaccination, these infections are associated with reduced mortality.

Keyphrases

cardiovascular events
coronavirus disease
sars cov
risk factors
type diabetes
coronary artery disease
cardiovascular disease